Description

The Schulich School of Medicine & Dentistry at The University of Western Ontario invites applications for a Tier 1 Canada Research Chair (CRC) in Mass Spectrometry ‘Omics for Novel Therapeutics. The successful candidate will be appointed to a full-time tenured joint appointment at the rank of Associate Professor or Professor in the Department of Biochemistry, in the Schulich School of Medicine & Dentistry, and jointly in the Department of Chemistry in the Faculty of Science.  The rank and tenure status will be commensurate with qualifications and experience. The successful candidate may be appointed to potential cross appointment(s) in other relevant departments at their request. The successful candidate will be expected to apply for a Tier 1 Canada Research Chair in the first available competition after their appointment.

In recognition of Western’s commitment to equity, diversity and inclusion, and in recognition of the underrepresentation of Women in our Chairholders and pursuant to Section 14 of the Ontario Human Rights Code, only applicants who self-identify as a woman will be considered for this CRC opportunity. The CRC Program includes individuals from Gender Equity-Seeking Groups in the designated group of Women. This includes individuals who self-identify as transgender, gender-fluid, non-binary and Two-Spirit. Applicants will be required to self-identify to the appointments committee members in their application for the position. Candidates must complete the CRC Application Form and submit it with their application materials. This information will be disclosed to members of the appointments committee responsible for the selection of candidates and senior administrative personnel supporting the committee. Self identification of applicants will not be disclosed to advisory members to the search committee or other departmental or faculty members. 

Mass Spectrometry ‘Omics (including Metabolomics, proteomics, lipidomics or any related area) can be used to study both healthy populations as well as many different acute and chronic diseases and the goal of this position is to build capacity and leadership in this critical research area. Identifying, characterizing and following the proteins, lipids 
or small molecules in populations and patient cohorts provides a functional readout on the molecular, cellular and system-wide processes.  This position can be in any area of interest but should demonstrate the ability to acquire, set up and maintain shared instrumentation. It is anticipated that the successful candidate will assume a leadership role for the shared Mass Spectrometry infrastructure in the BioCore, which is a key and growing component of the research infrastructure in the Department of Biochemistry, and serve as a mentor for junior faculty in this research area. 
This position is part of a larger initiative by Western University, the Schulich School of Medicine & Dentistry and the Faculty of Science to build a cross-departmental, world-class program in molecular biotherapeutics and diagnostics that spans the continuum from discovery to first-in-human trials. Successful candidates will join recent faculty hires 
across multiple departments with expertise in metabolomics, bioinformatics, biotherapeutics, imaging, inflammation, and public and indigenous health. They will have access to recent, professionally-managed, major on-site infrastructure investments in: multimodal and single-cell imaging, translational neuroimaging, high-throughput 
metabolomics, proteomics and genomics, pre-clinical biotherapeutic production, animal facilities, CL2 and 3 facilities, and GMP production. It is anticipated that successful candidates will participate in this initiative by providing their critical expertise in this continuum, and contribute to large-scale funding proposals, by working closely with clinician scientists, basic scientists and facility directors to advance these research priorities. 
The University of Western Ontario recognizes the potential impact that career interruptions can have on a candidate’s 
record of research achievement. Potential candidates are encouraged to explain within their application the impact that 
career interruptions have had on their record, and to submit a full career or extended CV to a chairholder position in 
cases where they have had career interruptions. 

Requirements

The successful candidate will hold a PhD or equivalent with advanced training in biochemistry, chemistry, biochemical engineering or another closely related area as and a demonstrated ability to both collaborate and to drive their own independent research. The successful candidate’s research interests will be supported by a record of impactful and significant publications as assessed by the principles of DORA. They should be a recognized national or international leader as exemplified by invited lectures and/or conference symposia as appropriate for their discipline and career stage. Candidates must demonstrate career-stage appropriate external peer-reviewed funding 
(e.g., CIHR, NIH). Successful candidates will have a record of incorporating EDID principles into their research, teaching and/or mentorship.  
In accordance with the criteria for a Tier 1 CRC appointment (www.chairs-chaires.gc.ca/) the successful candidate must be an outstanding and innovative world-class researcher who is recognized internationally as a leader in their field. The successful candidate must have demonstrated excellence in research, a record of external research funding, 
research impact, leadership in collaborative research environments, and high-quality training of graduate students and postdoctoral scholars. The applicant must have fluent written and oral communication skills in English. While this is a research-intensive position, the successful applicant should demonstrate enthusiasm for excellence in education as contributions to graduate and undergraduate education are expected.